Therapeutic management of atopic dermatitis.
Nurse Pract
; 49(6): 39-46, 2024 Jun 01.
Article
em En
| MEDLINE
| ID: mdl-38941080
ABSTRACT
ABSTRACT Atopic dermatitis (AD), a chronic inflammatory, pruritic skin disorder, is seen primarily in the pediatric population but can be found among all age groups. The symptoms of AD can cause embarrassment in patients and can interrupt daily activities and productivity, potentially resulting in avoidance of social situations. In addition to nonpharmacologic management, mainstay pharmacologic treatments for AD are topical medications including corticosteroids, calcineurin inhibitors, phosphodiesterase-4 inhibitors, and topical Janus kinase (JAK) inhibitors. Promising new drugs-oral JAK inhibitors and monoclonal antibodies-have emerged as new treatment options for moderate-to-severe AD.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dermatite Atópica
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article